FASLODEX is indicated for the treament of hormone receptor-positive metastatic breast
cancer in postmenopausal women with disease progression following antiestrogen therapy.
*Estrogen receptor |
OncologySTAT Mobile
Away from the office, hospital or computer? Put the power of Elsevier's vast oncology resources in your pocket!